Results 271 to 280 of about 88,356 (287)

Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma

Neuro-Oncology Advances, 2023
Benedito A Carneiro, Andrew B Lassman, Saiama N Waqar   +2 more
exaly  

The oncology market for antibody–drug conjugates

Nature Reviews Drug Discovery, 2021
Carolina, do Pazo, Khurram, Nawaz, Rachel M, Webster   +2 more
openaire   +2 more sources

Pharmacokinetics of trastuzumab deruxtecan (T-DXd), a novel anti-HER2 antibody-drug conjugate, in HER2-positive tumour-bearing mice

Xenobiotica, 2020
Masataka Oitate, Katsunobu Hagihara, Hideyuki Shiozawa   +2 more
exaly  

Antibody-drug Conjugate Targets, Drugs, and Linkers

Current Cancer Drug Targets, 2022
Beverly A Teicher, Joel Morris
exaly  

Antibody-Drug Conjugates

Sharad Agarwal, Ema Kikovska-Stojanovska
  +6 more sources

A glypican-1-targeted antibody-drug conjugate exhibits potent tumor growth inhibition in glypican-1-positive pancreatic cancer and esophageal squamous cell carcinoma

Neoplasia, 2021
Eri Munekage, Satoshi Serada, Minoru Fujimoto   +2 more
exaly  

Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody–drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresectable pancreatic cancer

Annals of Oncology, 2016
J F Liu, K N Moore, M J Birrer
exaly  

Comprehensive preclinical pharmacokinetic evaluations of trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate, in cynomolgus monkeys

Xenobiotica, 2019
Masataka Oitate, Hideyuki Shiozawa, Osamu Ando   +2 more
exaly  

Effective antitumor therapy based on a novel antibody-drug conjugate targeting the Tn carbohydrate antigen

OncoImmunology, 2016
Christine Sedlik, Frédéric Schmidt, Philippe De La Rochere   +2 more
exaly  

A Traceless Vascular‐Targeting Antibody–Drug Conjugate for Cancer Therapy

Angewandte Chemie - International Edition, 2012
Gonçalo J L Bernardes, Giulio Casi, Kathrin Schwager   +2 more
exaly